Advances in Encapsulating Marine Bioactive Compounds Using Nanostructured Lipid Carriers (NLCs) and Solid Lipid Nanoparticles (SLNs) for Health Applications

被引:0
|
作者
Favas, Rita [1 ,2 ]
Almeida, Hugo [1 ,2 ,3 ]
Peixoto, Andreia F. [4 ]
Ferreira, Domingos [1 ,2 ]
Silva, Ana C. [1 ,2 ,5 ]
机构
[1] Univ Porto, Fac Pharm, UCIBIO Appl Mol Biosci Unit, Lab Pharmaceut Technol, P-4050313 Porto, Portugal
[2] Univ Porto, Inst Hlth & Bioecon i4HB, Fac Pharm, Associate Lab, P-4050313 Porto, Portugal
[3] Mesosyst Invest & Investimentos Spinpark, P-4805017 Guimaraes, Portugal
[4] Univ Porto, Fac Ciencias, Dept Quim & Bioquim, LAQV REQUIMTE Associated Lab Green Chem Network Ch, P-4169007 Porto, Portugal
[5] Univ Fernando Pessoa, Fac Hlth Sci, FP I3ID Inst Invest Inovacao & Desenvolvimento, FP BHS Biomed & Hlth Sci Res Unit, P-4249004 Porto, Portugal
关键词
healthcare; cosmetics; food supplements; marine bioactive compounds; lipid nanoparticles; IN-VITRO; VITAMIN-E; FORMULATIONS; DELIVERY; BIOCOMPATIBILITY;
D O I
10.3390/pharmaceutics16121517
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
As life expectancy rises and modern lifestyles improve, there is an increasing focus on health, disease prevention, and enhancing physical appearance. Consumers are more aware of the benefits of natural ingredients in healthcare products while also being mindful of sustainability challenges. Consequently, marine bioactive compounds have gained popularity as ingredients in cosmetics and food supplements due to their diverse beneficial properties. Nonetheless, the use of some of these compounds is restricted by their low stability and poor aqueous solubility, necessitating solutions to overcome these limitations. In this context, lipid nanoparticles, such as solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs), have been investigated for their potential to protect and improve the absorption of molecules through various routes, including oral and cutaneous. Numerous studies have shown that nanoencapsulating these compounds and incorporating them into cosmetics and food supplements can be effective. However, this application remains unregulated at the global level and is not currently addressed by existing legislation. Additional in vivo studies in both animals and humans are necessary to fully assess safety concerns.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): recent advances in drug delivery
    Goo Yoon
    Jin Woo Park
    In-Soo Yoon
    Journal of Pharmaceutical Investigation, 2013, 43 (5) : 353 - 362
  • [2] Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam
    Khalil, Rawia M.
    Abd-Elbary, A.
    Kassem, Mahfoz A.
    Ghorab, Mamdouh M.
    Basha, Mona
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2014, 19 (03) : 304 - 314
  • [3] Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors
    Mehrdadi, Soheil
    ADVANCED PHARMACEUTICAL BULLETIN, 2023, 13 (03) : 512 - 520
  • [4] Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das, Surajit
    Ng, Wai Kiong
    Tan, Reginald B. H.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 47 (01) : 139 - 151
  • [5] Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Food-Grade Nanovehicles for Hydrophobic Nutraceuticals or Bioactives
    Tang, Chuan-He
    Chen, Huan-Le
    Dong, Jin-Ru
    APPLIED SCIENCES-BASEL, 2023, 13 (03):
  • [6] Preparation, characterization and in vivo pharmacokinetic evaluation of curcuminoids-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs)
    Dolatabadi, Shabnam
    Karimi, Maryam
    Nasirizadeh, Samira
    Hatamipour, Mahdi
    Golmohammadzadeh, Shiva
    Jaafari, Mahmoud Reza
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2021, 62
  • [7] Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration
    Song, Aihua
    Zhang, Xiaoshu
    Li, Yanting
    Mao, Xinjuan
    Han, Fei
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2016, 42 (08) : 1308 - 1314
  • [8] Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations
    Mura, Paola
    Maestrelli, Francesca
    D'Ambrosio, Mario
    Luceri, Cristina
    Cirri, Marzia
    PHARMACEUTICS, 2021, 13 (04)
  • [9] Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations
    Jansook, Phatsawee
    Fulop, Zoltan
    Ritthidej, Garnpimol C.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2019, 45 (04) : 560 - 567
  • [10] Amphotericin B-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): effect of drug loading and biopharmaceutical characterizations
    Jansook, Phatsawee
    Pichayakorn, Wiwat
    Ritthidej, Garnpimol C.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2018, 44 (10) : 1693 - 1700